CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 32 enrolled
Drug / intervention
controlled release carvedilol +1 moredrug
Likely dose
controlled release carvedilol 80 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01171183
NCT01171183Phase 2Completed
CompareCT.gov

Clinical Efficacy of Carvedilol for Psychostimulant Dependence

University of Arkansas·interventional·Posted Jul 28, 2010·Updated Jul 31, 2015

In Brief

A Phase 2 clinical trial evaluating controlled release carvedilol and Placebo for Cocaine Dependence and Cocaine Withdrawal. Completed, enrolled 32 participants across 1 site.

Detailed Summary

This study examines whether carvedilol prolongs abstinence in recently abstinent cocaine dependent participants.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCocaine Dependence, Cocaine Withdrawal
CountriesUnited States
CollaboratorsNational Institute on Drug Abuse (NIDA), Baylor College of Medicine

Timeline

Phase 2CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJul 28, 2010
Enrollment StartAug 1, 2010
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 15.9 years ago

Interventions

controlled release carvediloldrug

carvedilol (Coreg CR) 80 mg/day in once daily dosing for 12 weeks followed by a 2-week taper

Placebodrug

Placebo